Recent portfolio moves:
https://pbs.twimg.com/media/G_mhuQUWMAQPIX9?format=png&name=900x900
1. sold remainder $CNDS position acquired in 2020 Sep at $315.50; +216.4% profit and +24% CAGR
I either had to liquidate or increase size. China revenue share has increased to 18%. Its a matter of time for a next us-china trade dispute, where semi export controls is front and center each time and $SNPS, $CDNS are suffering. Since Lip Bu Tan left for Intel, EPS growth also stalled, as did the stock.
2. Opened two tracker positions in $OMDA ($15.06 entry), $FIGR (entry $63.12).
Healthcare is not my cup of tea, but I'll evaluate potential newsletter subscription off the outcome on OMDA. Can't force my interest w/o skin in the game
Figure - tokenization, cost savings in monetizing real esate equity, huge, unpenetrated TAM, high profitable growth story. Watchlist time have cost me, but had to find time to dig into materials a little bit more. Besides, crypto legislation could be another catalyst.
And finally entered into $CME at $282. Proxy play on volatility, retail activity, metals while US becomes banana republic. $CME had long held monopoly on yields futures market - $BGC (also looking into) is gaining share, but when serious volatility comes, $CME is still the place for deep liquidity. Recent news all point to record trading volumes. Low beta; valuation not demanding.
https://pbs.twimg.com/media/G_mqMx9W8AcI2aR?format=jpg&name=medium
https://pbs.twimg.com/media/G_mrPIoWIAAI_LA?format=jpg&name=large